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Abstract 
Introduction: Fibromyalgia is a condition with symptoms of pain, physical function difficulties, 
and emotional problems, but is also characterized by complaints of poor cognition (often called 
‘FibroFog’).  Over the last two decades, a number of studies have examined cognitive 
differences between individuals with and without fibromyalgia.  The purpose of the current study 
was to conduct a quantitative synthesis of these differences across multiple cognitive domains.   
Methods: Following Cochrane guidelines, we identified 37 eligible studies for analysis where 
persons with fibromyalgia (total n = 964) were compared to participants from age-matched 
control groups without fibromyalgia (total n = 1,025) on a range of neuropsychological 
measures.  Group differences between persons with fibromyalgia and healthy controls were 
examined for cognitive domains including processing speed, long- and short-term memory, and 
executive functions (inhibitory control, set shifting, updating, and accessing).  Random-effect 
meta-analyses were conducted to determine effect sizes for these differences in cognitive 
performance.   
Results: Fibromyalgia was significantly and negatively associated with performance on all 
domains of cognitive function.  The largest effect size was found for inhibitory control (g = 
0.61), followed by memory (g =  0.51 for short-term, 0.50 for long-term memory).  The smallest 
cognitive difference between those with fibromyalgia and controls was for set shifting (g = 0.30).   
Conclusion: These findings support the hypothesis that the self-reported cognitive impact of 
fibromyalgia is also found in objective neuropsychological measures.  Routine screening for 
cognitive dysfunction in those with fibromyalgia may be warranted in addition to assessment of 
the traditional fibromyalgia symptoms.  
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Introduction 
Fibromyalgia is a condition affecting 2% of the general population at any given time 
(Lawrence et al., 2008) with most being female (>90%; Schaefer et al., 2016). Common 
symptoms of fibromyalgia include pain, stiffness, fatigue, sleep dysfunction, and headaches 
(Bennett, 2009; Mease, 2005; Schmidt-Wilcke & Clauw, 2011).  Previously, fibromyalgia 
diagnosis involved pain lasting at least three months across five body quadrants (axial, left, right, 
upper, and lower segment pain) and the presence of 11 out of 18 tender points, places of high 
sensitivity to pressure pain (Wolfe et al., 1990).  Criteria was later revised to include presence of 
pain in 7 out of 19 regions, and ratings greater than 5 out of 12 on a newly created scale rating 
symptoms of fatigue, sleep, and cognition on difficulty from 0 (no problem) to 3 (severe) and 
general symptom severity from 0 (no symptoms) to 3 (a great deal) (Wolfe et al., 2010).  With 
addition of this symptom scale, one of the most common fibromyalgia symptoms was included: 
self-reported cognitive difficulties known as “FibroFog”.  To better understand this emerging 
symptom cluster, the current study examined objective difficulties with cognitive performance in 
those with fibromyalgia.   
  Approximately 75% of fibromyalgia patients report significant problems with 
concentration, memory and multitasking (Donaldson, Sella, & Mueller, 1998; Leavitt, Katz, 
Mills, & Heard, 2002).  In addition, self-reported cognitive difficulty is associated with higher 
levels of pain, stiffness, poor sleep, and elevated depression and anxiety symptoms in 
fibromyalgia (Leavitt et al., 2002; Wolfe et al., 2010).  Cognitive difficulties have been reported 
in focus groups (Arnold et al., 2008), surveys (Bennett, Jones, Turk, Russell, & Matallana, 
2007), and in observer reports of cognitive impairment from medical professionals (Zachrisson, 
Regland, Jahreskog, Kron, & Gottfries, 2002).  While cognitive difficulties are thought to be 
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relevant to clinical care in fibromyalgia, it remains unclear whether these subjective reports 
correspond to objective cognitive difficulties in fibromyalgia, which can impact quality of life, 
treatment adherence, and negative health outcomes (Skoog et al., 2005; Tesio et al., 2015; Zinn 
et al., 2004).  Better understanding of the impact of this pain condition on objective cognitive 
difficulties may help provide a more comprehensive view of FibroFog and its impact on daily 
living and health.  Moreover, prior research shows that the association between pain and 
cognitive performance is not universal across domains, but more specific to complex task 
completion (such as tasks involving executive functions) than simple processing tasks (Moore, 
Keogh, & Eccleston, 2012).  Thus, by understanding the objective impact of fibromyalgia on 
specific cognitive domains, clinicians may be able to predict and improve treatment outcomes for 
this population more accurately.   
To date, a large body of research has assessed task-based neuropsychological 
performance in fibromyalgia.  Overall, research has documented cognitive difficulties in several 
domains including processing speed (Reyes Del Paso, Montoro, & Duschek, 2015), short-term 
memory (Park, Glass, Minear, & Crofford, 2001), long-term memory (Cánovas, León, Roldán, 
Astur, & Cimadevilla, 2009), inhibtory control (Walitt, Roebuck-Spencer, Bleiberg, Foster, & 
Weinstein, 2008), and working memory (Coppieters et al., 2015).  However, some mixed results 
regarding specific cognitive domains have also been reported.  In a review of literature by Glass 
(2009), people with fibromyalgia show consistent difficulties in episodic/semantic memory and 
working memory (Cánovas et al., 2009), but there are other studies showing no signficant 
differences in other cognitive domains (Cánovas et al., 2009; Di Tella et al., 2015; Walitt et al., 
2008; Walteros et al., 2011), making generalizations from previous research more difficult.  In 
order to clarify the objective nature of cognitive problems in those with fibromyalgia, a meta-
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analysis is needed to quantitatively synthesize results across multiple studies and guide futher 
investigation.  
Theoretical Foundations for the Current Meta-Analysis 
Studies examining the cognitive difficulties in fibromyalgia and other chronic pain 
conditions have hypothesized compromised attention systems due to shared networks with pain 
(Cánovas et al., 2009 Correa, Miro, Martinez, Sanchez, & Lupianez, 2011; Glass et al., 2011).  
Eccleston and Crombez (1999) proposed that pain is an obstacle for efficient cognitive 
processing.  In this model, attention leads to selection of information salient to cognitive goals, 
which are triggered by internal and external stimuli.  Attentional resources, however, are limited, 
and cognitive goals must be selected by their degree of saliency. Due to the evolutionary 
mechanism of pain (i.e., escape and survival), pain-processing is prioritized at the cost of 
attentional resources for other goal-related behavior.  Consequently, Eccleson and Crombez. 
(1999) theorized that constant goal disruption by pain may cause cognitive difficulties 
throughout the different stages of the information processing model.  Applying this theory, the 
current study tested for cognitive difficulties in fibromyalgia throughout information processing 
domains using a model incorporating long-standing theories of working memory (Atkinson & 
Shiffrin, 1968; Baddeley & Hitch, 1974) and executive functioning (Miyake et al., 2000).   
The cognitive model guiding the current study describes the mechanics of information 
processing, which begins at sensory perception and ends with a behavioral response.  In this 
model, attended information is initially processed through sensory registries, and low-priority or 
task-irrelevant information is filtered out.  Relevant information is then stored into short-term 
memory, which is limited and held very briefly in systems specific to auditory-verbal and 
visuospatial information.  Rehearsal and elaboration can then move information into long-term 
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memory to be stored and recalled for an unlimited amount of time.  The storage of relevant 
information, however, is not sufficient to achieve goal-related behavior.  Instead, a central 
executive cognitively controls information to produce an appropriate response; such control is 
possible through specific, though related sets of executive functions within the central executive.   
Executive functions are higher-level cognitive processes implemented in goal creation, 
planning, and response execution (Lezak, Howieson, & Loring, 1983; Lezak, 2004).  Miyake et 
al. (2000) provided evidence for separate but non-orthogonal components of the central 
executive, falling into the subcategories of inhibition, set shifting, and updating, which are 
moderately interrelated.  Inhibiting involves purposive prevention of interference from prepotent 
responses (responses previously reinforced and associated with stimuli; Barkley, 2013); shifting 
involves changing mental sets to provide an appropriate response; and updating involves adding 
and deleting representations in working memory by goal relevance.  Recently, Fisk and Sharpe 
(2004) have expanded on the work of Miyake et al. (2000) with the addition of a new executive 
function known as accessing (often measured as verbal fluency), which involves executive action 
to retrieve information from long-term memory.  Assessing individual executive functions may 
add additional insight into the integrity of the central executive in fibromyalgia.  
 The current study examines differences between persons with fibromyalgia and healthy 
adults on cognitive function including processing speed, short-term memory, long-term memory, 
and executive functions.  The potential moderating role of age is also examined as older adults 
with fibromyalgia may show greater cognitive difficulties due to age-related declines.  
Methods 
Data sources 
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The current study employed a systematic search of the literature using the Cochrane 
Collaborations (Higgins & Green, 2011) and the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009).  
Pubmed, PsychInfo, and OVID databases were searched (from January 1950 to July 2015) using 
Boolean terms including “fibromyalgia” and words describing cognition: (“fibromyalgia” AND 
“attention,”); (“fibromyalgia” AND “cognition”); (“fibromyalgia” AND “cognitive”); 
(“fibromyalgia” AND “executive”); (“fibromyalgia” AND “memory”); (“fibromyalgia” AND 
neuropsychological”).  Identified articles were then indexed by database and key terms.  
Study selection and inclusion  
Two steps were involved in study article selection (see Figure 1).  The first step involved 
two independent reviewers (TB, MB) screening all possible citations to filter out articles which 
did not relate to fibromyalgia and cognition based on information from titles and abstracts.  The 
key terms searched in the databases provided 2,355 citations, and after removing duplicates (n = 
882), there were 1,472 articles to be screened.  After review, 1,367 articles were excluded based 
on irrelevance to the meta-analysis focus (fibromyalgia and task-measured cognitive 
performance).  For example, 28.9% (n = 396) involved diagnosis and treatment/interventions for 
fibromyalgia, 28.9% (n = 396) did not pertain to objective task-measured cognition, 19.2% (n = 
263) were not peer-reviewed empirical articles (e.g., reviews, commentaries), 12.5% (n = 171) 
did not specifically pertain to fibromyalgia, and 8.2% (n = 112) related to neurophysiological 
aspects of fibromyalgia with no cognitive performance measures.  Other reasons for exclusion 
included the use of animals, no control group, or the article was only available as an abstract 
(less than 1% for each).  A total of 105 studies were deemed eligible for inclusion in the next 
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step of screening, with high inter-rater reliability above chance agreement (Kappa = .78, p < 
.001).  
The second step involved applying the following inclusion criteria to each study: (1) The 
study was not characterized by comorbid conditions that included any neurological condition 
with cognitive effects (including all forms of dementia, neural degeneration or demyelinating 
disorders, epilepsy, sleep disorders, ADHD) in the control group or in the patient group (other 
than a primary diagnosis of fibromyalgia); (2) the study looked at objective task-measured 
cognitive performance; (3) the study did not assess cognition with solely a mental status exam or 
other screening measure; (4) the study was peer-reviewed; (5) the study included a healthy age-
matched control group; (6) the data were not related to the effects of a drug or treatment 
intervention (baseline comparisons only); (7) the paper was not a review or conference abstract; 
(8) the study included human participants and did not investigate animals; (9) the study did not 
make use of emotion-inducing stimuli (i.e., did not use negative or pain-related stimuli) during 
cognitive tasks, which includes the use of non-neutral (positive or negative) stimuli; (10) the 
article was available in English; and (11) the study pertained to fibromyalgia specifically (not 
aggregated with other pain conditions).  
Of the 105 articles included in this step of eligibility, 39 studies were initially found to 
meet the criteria while 66 articles were excluded (98% reviewer agreement).  Disagreements 
were settled by discussion between MB and TB as well as consulting co-authors.  Further 
inspection led to the exclusion of two additional articles, one which was not fully available in 
English, and one which did not have an age-matched control group (total excluded = 68).  The 
primary reasons for article exclusion were as follows: of the 68 studies excluded, 25 (36.76%) 
did not include a healthy (age-matched) control group, 16 (23.53%) did not look specifically at 
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cognitive performance, 10 (14.71%) were not full-text research studies (e.g., review, 
commentary, conference abstract), 6 (8.82%) did not pertain to fibromyalgia specifically, 3 
(4.41%) were not peer-reviewed, 4 (5.88%) were not available in English, 1 (1.47%) included 
emotional stimuli (induced pain), and 3 (4.41%) only assessed cognition using a mental status 
exam or other screening measure.  This process left 37 eligible studies for data extraction and 
subsequent analyses.  It is important to note that these numbers reflect primary reasons for 
exclusion, as many of the excluded articles failed to meet multiple inclusion criteria.  For this 
step of selecting the 37 of 105 potential articles, there was a high inter-rater reliability (Kappa = 
.96, p < .001).  All included studies with descriptive information can be seen in Table 1.  
Data extraction 
Data were extracted by two independent reviewers (TB, MB) using a standardized form 
(Berryman et al., 2013) tailored to current needs.  Data extraction included keywords and the 
location of the study (Europe, North America, etc.).  Next, data regarding sample size, 
participant gender, participant age, and other demographic information were examined.  Data 
was collected for each cognitive task, including the name of the test, the cognitive domain 
assessed, and the means and standard deviations of scores in the fibromyalgia and the healthy 
control group.  Moreover, score means, standard deviations, sample sizes, sample mean age, t-
statistics, and p-values were recorded to compute effect sizes.  For each measure, the domain that 
the measure most directly assessed was determined by study description and initial review (e.g., 
Stroop – inhibition), scoring type (response time, accuracy, or errors), as well as primary stimuli 
type (verbal auditory versus visuospatial).  
Data synthesis  
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Outcome measures from each study were synthesized into cognitive domains of interest 
guided by established theoretical cognitive models (Atkinson & Shiffrin, 1968; Baddeley & 
Hitch, 1974; Miyake et al., 2000).  These included processing speed, short-term and long-term 
memory, and executive functions of selective attention/response inhibition, set shifting, working 
memory/updating, and accessing.  Because cognitive tasks can be measured by accuracy (higher 
scores indicating better performance), errors (more errors indicating worse performance) or 
response time (higher scores indicating worse performance), effect sizes were transformed so 
that higher effect sizes indicated worse performance (expected direction). 
Data pooling  
For each group comparison, effect sizes were converted into standardized mean 
differences using Hedges’ g, calculated from group means and pooled standard deviations for 
each cognitive task or directly from Cohen’s d.  Hedges’ g statistic was calculated using 
OpenMeta software (Wallace et al., 2012).  In cases where standard errors were reported, 
standard deviations were calculated by multiplying the standard error by the square root of the 
sample size for each group.  Hedges’ g is similar to Cohen’s d and can be interpreted as how 
many standard deviations the fibromyalgia group is performing above or below the healthy 
control group.  Unlike Cohen’s d, Hedges’ g removes the bias of small and unequal sample sizes, 
which may overestimate group differences.  Effect sizes for Hedges’ g are equivalent to that of 
Cohen’s d, where small, medium, and large effects correspond to values of .20, .50, and .80 
(Cohen, 1988).  An estimate of Hedges’ g is considered significant if 0 is not included in the 
95% confidence interval (Nakagawa & Cuthill, 2007).   
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Data were collected from independent samples to meet the assumption of independence 
in our statistical analyses, allowing only one effect size for a cognitive domain to be collected 
from each study.  Thus, reviewers decided on which measures of a certain domain were most 
valid for inclusion (had high construct validity) based on current neuropsychological assessment 
texts and research (Lezak, 2004; Strauss, Sherman, & Spreen, 2006) and discussion with co-
authors.  In many cases, studies used multiple measures of the same domains, for which 
composite Hedges’ gs were calculated to provide an optimal estimate. For example, a study 
using 2 measures of processing speed would provide 2 corresponding effect sizes for that 
domain, which were then averaged to make a composite effect size for processing to meet the 
assumption of independence.  In the current study, random-effects meta-analysis (Borenstein, 
Hedges, Higgins, & Rothstein, 2010) was then used to provide pooled Hedges’ gs for each 
cognitive domain, along with 95% confidence intervals and a measure of between-study 
heterogeneity (I2).   
Risk of bias assessment  
Risk of bias was assessed using guidelines provided by the Cochrane Collaboration 
(Higgins & Green, 2011).  Each article was strictly assessed on the criteria provided, including 
domains of selection bias (biased from non-random generation of groups, non-comparable 
recruitment), attrition bias (bias due to amount, nature, or handling of missing data), reporting 
bias (bias due to selective outcome reporting), and other bias (bias due to other sources identified 
by author reviewers).  Other important concerns derived from reviews were noted, such as study 
limitations and accurate use and interpretation of neuropsychological measures.  To handle bias, 
any studies that were at high risk were not included in analyses.  
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Statistical analysis  
Analysis was conducted using OpenMeta software (Wallace et al., 2012) using the 
random-effects model with the DerSimonian method (DerSimonian & Laird, 1986).  Random-
effects analysis was used following the logic that each study might have its own true effect size 
due to study-specific characteristics with the goal of the current study to provide an estimate for 
the average of these true standard mean differences and not one true value for these differences.   
Furthermore, random effect models were used to obtain measures of heterogeneity known as I2, 
which specifies the percent of variability in the effect size across studies.  In addition to the 
pooled standard mean differences (Hedges’ g), 95% confidence intervals, I2 estimates, and forest 
plots for each cognitive domain were produced.  
Results 
Characteristics of included studies  
  Of the 37 studies analyzed, 26 were based in Europe (71.1%), 9 in North America 
(23.7%), and 2 (5.3%) in Asia.  Regarding participant characteristics, the mean age for 
participants with fibromyalgia across these studies was 47.85 (SD = 8.23), and the mean age for 
the healthy control samples was 45.99 (SD = 8.83).  The average percent of females in the 
fibromyalgia samples was 96.4%, and 94.5% in the healthy control groups. Either years of 
education or highest education level was recorded from each study. Using studies with available 
data on years of education (15 studies), the average education for participants with fibromyalgia 
was 12.93 years (SD = 3.61), and 13.34 years (SD = 2.68) for participants in the healthy control 
groups.  A total of 964 participants with fibromyalgia and 1,025 age-matched participants 
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without fibromyalgia were included from these studies. Characteristics of all studies can be seen 
in Table 1.    
Regarding bias, five studies showed unclear selection bias due to a lack information on 
recruitment, two had unclear selection bias due to attrition bias (unclear handling of missing 
data), and three had unclear reporting biases due to incomplete output reporting.  Because none 
of the studies showed a high risk of bias, all studies were used for subsequent analyses. Meta-
analytical results described by cognitive domain below are also summarized in Table 2.  
Processing Speed 
 Information processing speed, typically defined as the average time elapsed from stimuli 
presentation to a task-appropriate response, was measured in 10 studies using diverse measures.  
The main measures involved the speed at which one completed a simple task or the number of 
accurately completed problems within an allotted time.  These measures included the Digit 
Symbol Substitution task (Wechsler, 1997), Pattern/Letter/Number Comparison (Salthouse & 
Babcock, 1991), and Trail Making Task Part A (Reitan, 1958), as well as congruent conditions 
during the Attention Network Task-Interactions (ANT-I; Callejas, Lupiánez, & Tudela, 2004) 
and Stroop task (Stroop, 1935).  Measures also included reaction times on a lab-developed 
mental arithmetic task (Montoro, Duschek, Muñoz Ladrón de Guevara, Fernández-Serrano, & 
Reyes del Paso, 2015), a cued reaction time task (Montoro et al., 2015), and reaction time on the 
Psychomotor Vigilance Task (Dinges & Powell, 1985).  Looking at measures of response speed 
(14 outcome measures), there was a larger effect size (average g = .59 than for measures of 
accuracy (4 outcome measures; average g = .49).  However, as seen in Figure 2, the random-
effects model for processing speed showed a significant and medium-sized difference between 
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those with fibromyalgia and healthy control groups using both measures of response time and 
accuracy (g = .46, 95% CI: .25 to .67), with no significant between-study heterogeneity (I2 = 
39.08%, p = .097).  
Memory  
Short-term memory 
We identified 12 studies that assessed short-term memory, defined as the ability to retain 
information over a very brief period of time.  These tasks were mainly comprised of immediate 
recall and recognition of verbal and visuospatial stimuli.  Measures included outcomes from 
ANAM Code Substitution-Immediate Recall (Kane & Reeves, 1997), Attentional Blink 
(McLaughlin, Shore, & Klein, 2001), Benton Forms and Lines (Benton, 1994), CERAD-
Immediate Recall (Morris et al., 1989), Corsi Block Test Forward (Kessels, van Zandvoort, 
Postma, Kappelle, & de Haan, 2000), Digit Span Forward (English and Korean; Orsini et al., 
1987; Yeom, Park, Oh, Kim, & Lee, 1992), Kimura Recurring Figures Recognition Test 
(Kimura, 1963), 10/36 Spatial Recall Task (Achiron et al., 2005), Rey Auditory Verbal Learning 
Task immediate recall  (English and Korean versions; Rey, 1964), Rey Complex Figures Task-
Immediate recall (Rey, 1941), Spatial Span Forward (Ha et al., 2002), and Wechsler’s Verbal 
Memory test (Wechsler, 2004).  Additional short-term memory measures included lab-developed 
tasks, such as a virtual reality version of the Hole Board Test (Oades & Isaacson, 1978), known 
as the Boxes Room task (Cánovas et al., 2009), as well as classic free recall and recognition 
tasks. Looking at tasks using auditory/verbal stimuli, there was a moderate-sized difference 
between those with fibromyalgia and healthy controls (17 outcome measures; average g = .36).  
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The effect size for this difference was larger for visuospatial tasks (14 outcome measures; 
average g = 1.07).  
Composite effect sizes were made for each study. For example, the average effect size on 
measures of short-term memory was calculated for Canovas et al. (2009), which included mean 
differences on Digit Span Forward, Corsi Block Forward, and the 10/36 Spatial Recall Test.  
Using composite effect sizes for 12 studies, random effects analysis confirmed a moderate 
difference in short-term memory ability in fibromyalgia compared to healthy adults (g = .51, 
95% CI: .29 to .74), seen in Figure 3.  There was also a significant amount of between-study 
heterogeneity (I2 = 46.99, p = .036), suggesting substantial differences in short-term memory 
measurement and study characteristics.  
Long-term memory  
 Many of the studies examining short-term memory also included delayed recall 
conditions that measured a person’s ability to retrieve information after a pre-specified delay of 
time.  These measures included delayed recall and recognition subtests of the 10/36 Spatial 
Recall Task (Achiron et al., 2005), 15-item Rey Memory Test (Rey, 1964), ANAM Code 
Substitution delayed (Kane & Reeves, 1997), CERAD-Delayed Recall and Recognition (Morris 
et al., 1989), Code Memory Test Part 1 (Levander & Elithorn, 1987), Complex Figure Test-
Delayed Recall (Osterrieth, 1944); Rey Auditory Verbal Learning Task (English and Korean 
versions; Rey, 1964), Randt Memory Task (Randt, Brown, & Osborne, 1983), Rey Figure (15-
min and 5-min delay recall; Rey et al., 1941), Wechsler Memory Test-Delayed Recall (Wechsler, 
2004), as well as paradigm free recall task. Of the eligible studies, 11 studies assessed long-term 
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memory.  The average effect size for tasks using auditory/verbal stimuli was .49 (11 outcome 
measures), and was .53 for visual-spatial stimuli (5 outcome measures).   
 As seen in Figure 4, random-effects modeling showed a significant small to moderate 
difference in long-term memory ability in fibromyalgia compared to healthy adults (g = .50, 95% 
CI: .28 to .72).  There was not a significant amount of between-study heterogeneity for long-term 
memory (I2 = 39.76, p = .084).  
Executive Functions 
Inhibitory control 
 Eighteen studies assessed inhibitory control, involving the prevention of inappropriate 
responses (response inhibition) and ability to ignore goal-irrelevant stimuli (selective attention).  
The primary measure of inhibitory control was the interference score from the classic Stroop task 
(Stroop, 1935) but also included interference calculated from the Go/No-Go paradigm (Fillmore 
& Rush, 2002), Coding Memory Test Part 2 (a measure of inhibition to task-irrelevant verbal 
stimuli, i.e., proactive interference; Levander & Elithorn, 1987), and the Test of Everyday 
Attention (TEA)-Selective Attention subscale (Robertson, Ward, Ridgeway, & Nimmo-Smith, 
1994).  
 Across these instruments, moderate difficulties were found for the Stroop task (12 
outcome measures; g = .61), and the TEA-Selective Attention (1 outcome measure; g = .54), 
whereas differences on the Go/No-Go paradigm were small (2 outcome measures; g = .34).  As 
seen in Figure 5, results from the random effects meta-analysis showed a moderate-to-large 
difficulty in inhibitory control across these measures that was statistically significant comparing 
those with fibromyalgia to healthy controls (g = .61, 95% CI: .38 to .83).  There was a large 
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amount of heterogeneity in effect sizes (I2 = 65.66, p <.001), greater than the amount expected 
by chance.  Sensitivity analyses revealed that removing the measure of selective attention did not 
reduce heterogeneity (I2 = 67.53%, p < .001) or significantly change the average of the standard 
mean differences (g = .61, 95% CI: .37 to .85).  This indicates that pooling estimates of selective 
attention and response inhibition did not confound the standard mean difference.  To test if the 
small differences found on the Go/No-Go paradigm were driving heterogeneity in the true effect 
size, the model was re-analyzed without this measure.  After removing the Go/No-Go paradigm 
from the model, there was still a significant amount of between-study heterogeneity (I2 = 
68.17%, p = .001), though the standard mean effect size increased (g = .63, 95% CI: .39 to .88).  
Thus, the differences in inhibitory control appear to vary significantly between studies, and this 
was not accounted for by inclusion of both selective attention and response inhibition tasks or 
inclusion of Go/No-Go paradigm.   
Set shifting 
 For the total eligible studies, seven assessed set shifting in fibromyalgia, which is the 
ability to swtich between tasks, operations, and mental sets (i.e., cognitive flexibility).  Measures 
included the Trail Making Task Part B (TMT-B; Reitan, 1958) and the number of perseveration 
errors on the Wisconsin Card Sorting Task (WCST; Rao, Hammeke, & Speech, 1987).  
 The average difference between those with fibromyalgia and controls for TMT-B was 
moderate (5 outcome measures; g = .44) and larger than shown for performance on the WCST (2 
outcome measures; g = .06).  As shown in Figure 6, a random-effects model showed that the 
average of standard mean differences was statistically significant, with worse set shifting 
abilities in fibromyalgia compared to healthy adults, but this effect was small (g = .30; 95% CI: 
.11 to .49). There was not significant heterogeneity between studies (I2 = 0.00, p = .490).  
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Updating 
Seventeen studies measured updating, defined as adding goal-relevant information and 
omitting goal-irrelevant information from active memory.  Commonly used measures which 
involve numerical-verbal information included Digit Span Backward (Orsini et al., 1987), n-back 
task (Kirchner, 1958), accuracy on lab-developed mental arithmetic tasks (Montoro et al., 2015), 
math and letter-number sequencing subtests of the Automated Neuropsychological Assessment 
Metrics (ANAM; Bleiberg, Kane, Reeves, Garmoe, & Halpern, 2000) and Wechsler Adult 
Intelligence Scale (WAIS-III; Wechsler, 1997), and complex span tasks including Operational 
Span Task (OSPAN; Turner & Engle, 1989) and Reading Span tasks (Daneman & Carpenter, 
1980).  Along with tasks based on numerical-verbal information are tasks based on other forms 
of primary stimuli.  The Auditory Consonant Trigrams paradigm (Stuss, Stethem, & Pelchat, 
1988), the Paced Auditory Serial Addition Task (PASAT; Gronwall, 1977), and the TEA-
Working Memory subscale (Robertson et al., 1994) were used to measure updating of auditory 
information, the Corsi Block Test Backward (Kessels et al., 2000), and failure to maintain set 
during the WCST (indicative of difficulties with updating; Rao et al., 1987) were used to 
measure updating ability for visuospatial information. 
On average, the largest differences were found on complex span tasks (3 outcome 
measures including OSPAN and Reading Span, g = .93), followed by the PASAT (4 outcome 
measures; g = .88) and the Digit Span Backward (8 outcome measures; g = .45).  The smallest 
differences were found on arithmetic tasks (5 outcome measures; g = .36), n-back (3 outcome 
measures; g = .33), and failures to maintain set on WCST (2 outcome measures; g = .25).  
Moreover, tests which primarily used auditory/verbal information showed larger differences (29 
outcome measures; g = .55) than those using visuospatial stimuli (4 outcome measures; g = .34).  
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As seen in Figure 7, random effects modeling confirmed a significant small to moderate 
difficulty in updating ability in fibromyalgia (g = .51; 95% CI: .33 to .69); and there was 
significant between-study heterogeneity in the standard mean difference (I2 = 44.14%, p = .026).  
Accessing 
Six studies evaluated accessing, the purposeful retrieval of information from remote 
memory.  Accessing was measured with tasks of verbal fluency, where participants name as 
many words as possible in a semantic category within a limited amount of time. These included 
the Animal Fluency Task (Morris et al., 1989) and Controlled Oral Word Association Test 
(COWAT)-FAS task (Benton & Hamsher, 1976).  
On the FAS task, there was an average moderate difficulty (5 outcome measures; g = 
.53).  On the Animal Fluency Task, participants with fibromyalgia had better performance 
compared to healthy controls (1 outcome measure; g = -.22), though this was non-significant 
(95% CI: -.65 to .20).  As shown in Figure 8, the random-effects model showed a modest 
difference in accessing in fibromyalgia (g = .38, 95% CI: 0.03 to 0.73), though there was 
significant heterogeneity (I2 = 62.88%, p = .019).   After removing the Animal Fluency Task, the 
standard mean difference increased (g = .52, 95% CI: .25 to .78) and heterogeneity was no longer 
present (I2 = 18.55%, p = .297).  The sample using the Animal Fluency Task involved older 
adults with fibromyalgia, which may have led to increased heterogeneity in effect size.  
Effects of Sample Age 
 To test the possibility that higher sample age may lead to greater group differences, 
standard mean differences were meta-regressed on sample age for all cognitive domains with at 
least ten or more studies.  Sample age was significantly associated with differences in long-term 
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memory (b = -.03, 95% CI: -.05 to -.002).   No significant associations were seen for short-term 
memory (b = -.02, -.040 to .002, p = .071), inhibitory control (p = .767), updating (p = .662), or 
processing speed (p = .521).  Approximately 70% of differences in long-term memory, and 57% 
of differences in short-term memory were accounted for by the fibromyalgia sample age. 
Overall, studies with higher sample ages showed smaller differences between the fibromyalgia 
and healthy control participants on measures of long-term memory (i.e., delayed 
recall/recognition).   
Discussion 
The current study found significantly worse performance on neuropsychological testing 
for those with fibromyalgia compared to healthy controls for all investigated domains, ranging 
from small to moderate magnitude.  This supports the idea that FibroFog involves both self-
reported and objective problems in cognition.  Comparing effect sizes, the largest difference 
between fibromyalgia participants and healthy controls was for the domain of inhibitory control 
(g = .61), which includes measures of selective attention and response inhibition.  Effect sizes for 
processing speed, short-term and long-term memory, and updating were medium, ranging from 
.46 to .51.  Small differences were found for set-shifting and accessing, ranging from .30 to .38.  
Greater problems with inhibitory control parallels research showing substantial overlap in neural 
networks of inhibition and pain perception, and are in line with the hypothesis that consumption 
of attentional resources for constant pain perception can impair activation of inhibitory systems 
in fibromyalgia (Glass et al., 2011).  Findings also provide objective evidence for the self-
reported difficulties of mental slowing, memory loss, information overload, and difficulties 
multitasking in those with fibromyalgia (Leavitt & Katz, 2011; Leavitt et al., 2002).   
FIBROMYALGIA AND COGNITION  22 
 
 
 
Our results showed some selective difficulties in subdomains of executive function and 
memory, as defined by Miyake et al. (2000) and Baddeley and Hitch. (1974).  For example, there 
appeared to be more difficulties in inhibitory control and updating than in set shifting or 
accessing.  In addition, memory differences were larger for short-term compared to long-term 
memory; and visuospatial memory differences were larger than verbal memory differences. 
While some cognitive domains appeared to show larger differences than others, the finding of 
statistically significant differences across all measured domains may argue for impairment in the 
central executive which would lead to memory problems and slower processing speed.  Thus, 
incorporating measures tapping into overall executive control and attention may be worthwhile 
in clinical and research settings for this population (Unsworth, Schrock, & Engle, 2004).   
We also found that greater sample age was associated with smaller differences between 
individuals with fibromyalgia and age-matched control participants on measures of long-term 
memory (and just beyond statistical significance on measures of short-term memory), contrary to 
the idea that differences would increase with sample age.  One explanation is that normal 
cognitive aging may reduce the discrepancy between persons with fibromyalgia and healthy 
peers on measures of memory encoding and retrieval.  However, there was generally a lack of 
older adults included in the samples from previous research, and all studies were cross-sectional, 
preventing true measurement of cognitive trajectories. This highlights the need for research 
looking at cognitive aging in fibromyalgia.  
It is important to note that although pain has been hypothesized to cause cognitive 
disruption, it is also possible that cognitive difficulties may contribute to maintenance or 
exacerbation of pain difficulties in fibromyalgia.  For example, the attentional disengagement 
theory purports that difficulties shifting between mental sets and inhibiting other mental sets 
FIBROMYALGIA AND COGNITION  23 
 
 
 
leads to greater rumination on negative self-referent material (Koster, De Lissnyder, Derakshan, 
& De Raedt, 2011).  Among persons with fibromyalgia, difficulties in set shifting and inhibitory 
control, highlighted in the current meta-analysis, may lead to intrusions of catastrophizing mental 
sets and greater rumination about pain.  Among healthy adults, poor inhibition has been 
associated with lower tolerance of pain and greater attention to pain (Oosterman, Dijkerman, 
Kessels, & Scherder, 2010; Verhoeven et al., 2011), and poor set shifting is associated with more 
persistent pain (Attal et al., 2014).  Therefore, difficulties may explain the lack of top-down pain 
modulation in fibromyalgia.  
 Findings from the current meta-analysis should be interpreted considering limitations.  
Primarily, the meta-analysis was unable to control for many possible confounds, including 
psychological disorders and medication use.  A theoretical understanding of the impact of 
chronic pain on cognitive performance is limited without better understanding of depression and 
anxiety that is often found in these patient populations (Bair, Robinson, Katon, & Kroenke, 
2003).  In general, depression severity has been negatively related to cognitive performance, 
especially on measures of processing speed, executive function, and episodic memory 
(McDermott & Ebmeier, 2009), and this association has also been found for measures of 
memory performance in fibromyalgia (Suhr, 2003).  Therefore, future research should control for 
depressive symptoms in statistical analyses or provide comparisons between subsamples with 
and without depression diagnosis, though several of the studies included in the current meta-
analysis did this (Landro, Stiles, & Sletvold, 1997; Tesio et al., 2015; Walteros et al., 2011).  
Finally, medication use may lead to worse cognitive performance in fibromyalgia compared to 
participants in the healthy control groups.  Current recommended treatments for fibromyalgia 
include antidepressant drugs and pregabalin as well as pain relief from various opioid therapies.  
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Cognitive side effects are possible for these drugs (Zaccara, Gangemi, Perucca, & Specchio, 
2011).  To date, it is not clear how recommended drugs impact cognitive performance of these 
patients.  In addition to unmeasured variables that may affect cognitive performance in those 
with fibromyalgia, methodological differences may have contributed to the heterogeneous effect 
sizes found for several cognitive domains.  Foremost, many studies did not match controls on 
measures of estimated premorbid intelligence and three did not match on education.  Matching 
control samples on these individual differences is important, as lower premorbid intelligence and 
lower years of education (i.e., lower cognitive reserve) may lead to overestimation of cognitive 
difficulties in fibromyalgia.  Additionally, many studies recruited persons with fibromyalgia in a 
different manner than healthy control participants.  Almost all the studies used physician referral 
or recruitment of fibromyalgia patients from healthcare clinics, while healthy control participants 
were recruited by community/campus advertisement, or through word-of-mouth.  Though not 
tested in this study, differences in recruitment methods may lead to sample biases as persons 
recruited from clinical settings may differ from those recruited in communities (i.e., more health 
problems).  Differences in cognition may also be affected by other control group characteristics.  
For example, most of the control groups volunteered without financial compensation, which may 
have led to a self-selection bias of participants who are internally motivated and show higher 
cognitive function due to greater cognitive effort.  In addition, a few studies did not screen for 
issues of pain (not related to fibromyalgia), medication use, or history of psychiatric disorders in 
the control group.  All included studies were cross-sectional and do not allow researchers to 
determine whether fibromyalgia leads to cognitive decline.  Another limitation to be considered 
is that most study participants were middle-aged (range = 36.20 to 59.40), limiting the 
generalizability of findings to other age groups.   
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We also note statistical considerations.  First, there were differences in the amount of 
included studies within each cognitive domain.  For instance, seven studies measured set-shifting 
and seventeen studies measured inhibitory control.   Unequal number of included studies should 
be considered when making comparisons across domains on between-study heterogeneity as 
fewer included studies leads to less valid tests and non-significance should not be interpreted as 
homogeneity (Higgins, Thompson, Deeks, & Altman, 2003).  Lastly, the large sample sizes 
accumulated from included studies could result in Type 1 error.  For this reason, effect sizes 
rather than significance alone are important to consider.  
Conclusion  
 The current meta-analysis strongly supports cognitive difficulty as a significant symptom 
cluster in fibromyalgia.  A remaining question is whether we can improve cognitive difficulties 
in fibromyalgia.  Improving pain and sleep, for example, may help reduce FibroFog (Suhr, 
2003). There is also some evidence for more direct interventions to improve cognitive 
performance.  For example, transcranial direct current stimulation has been found in some 
studies to improve processing speed, inhibition, memory, and accessing in fibromyalgia (Baudic 
et al., 2013; Curatolo et al., 2017).  Cognitive-behavioral therapy may also lead to improved 
executive functions and alertness (Miró et al., 2011), possibly by rerouting attentional resources 
away from pain toward more adaptive behaviors (i.e., behavioral activation).  Lastly, physical 
activity has been shown to improve short-term memory, updating, and accessing in those with 
fibromyalgia (Munguía-Izquierdo & Legaz-Arrese, 2007).  Though more studies are needed to 
determine the clinical utility of neurocognitive interventions, symptoms of FibroFog could be 
modifiable.  Helping physicians and patients see through FibroFog will continue to be a 
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worthwhile endeavor with the potential for providing a better life for those living with this 
challenging condition.   
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